Chromogenic method for the in vitro quantitative determination of Factor VIII (FVIII) activity, in human citrated plasma or FVIII concentrates, using an automated method. This method is for the
detection of FVIII deficiency states and monitoring of replacement therapy (except Emicizumab) on patients who are suspected of congenital or acquired deficiency and potency estimation of FVIII
concentrates.
Learn more about Factor VIII
Related Products
| Reference | Product name | Packaging | Categories |
| 221402 | BIOPHEN™ Chromogenic Factor VIII - small | 2 x 50 tests | Chromogenic Assay |
| 221406 | BIOPHEN™ Chromogenic Factor VIII - large | 2 x 120 tests | Chromogenic Assay |
| 227102 | BIOPHEN™ Chromogenic Factor VIII variant | 2 x 50 tests | Chromogenic Assay |
| RK039A | ZYMUTEST™ Anti-Factor VIII IgG monostrip | 4 x 8 tests | ELISA |
| 223201 | BIOPHEN™ Normal Control Plasma | 12 x 1ml | Controls |
| 223301 | BIOPHEN™ Abnormal Control Plasma | 12 x 1ml | Controls |
| 222101 | BIOPHEN™ Plasma Calibrator | 12 x 1ml | Calibrator |
| DP040A | Factor VIII Deficient Plasma - small | 1ml | Deficient Plasma |
| DP040K | Factor VIII Deficient Plasma - large | 6 x 1ml | Deficient Plasma |
| 5D-47119F | Human Factor VIII Inhibitor Plasma, Mild, Frozen | 1mL | Inhibitor Plasma |
| 5D-47119L | Human Factor VIII Inhibitor Plasma, Mild, Lyophilized | 1mL | Inhibitor Plasma |
| 5D-48119F | Human Factor VIII Inhibitor Plasma, Moderate, Frozen | 1mL | Inhibitor Plasma |
| 5D-48119L | Human Factor VIII Inhibitor Plasma, Moderate, Lyophilized | 1mL | Inhibitor Plasma |
| 5D-49119F | Human Factor VIII Inhibitor Plasma, Severe, Frozen | 1mL | Inhibitor Plasma |
| 5D-49119L | Human Factor VIII Inhibitor Plasma, Severe, Lyophilized | 1mL | Inhibitor Plasma |
Antibodies Chromogenic Substrates Purified Proteins
